Haffner Energy Reports Annual Results for Fiscal Year 2024-2025
Globenewswire· 2025-06-30 14:00
Haffner Energy Reports Annual Results for Fiscal Year 2024-2025 Strategic milestones were reached, opening up the prospect of a commercial and economic ramp-up in the current financial year Vitry-le-François, France - June 30, 2025, 08:00am (CEST) 2024-2025, a year of milestones demonstrating Haffner Energy's technological maturity: commissioning of the Marolles showcase site and green hydrogen production kick-off; signature of a first contract essential to the development of a hydrogen, electricity, and ...
Notice of Digitalist Group Plc’s Extraordinary General Meeting
Globenewswire· 2025-06-30 14:00
Digitalist Group Plc 30 June 2025 at 09:00 NOTICE OF DIGITALIST GROUP PLC’S EXTRAORDINARY GENERAL MEETING Notice is given to the shareholders of Digitalist Group Plc (“Company”) of the Extraordinary General Meeting to be held on Wednesday 13 August 2025 at 10 a.m. at the address Siltasaarenkatu 18-20 C, 00530 Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 9.15 a.m. Coffee will be served before the meeting to particip ...
NBPE Announces Transaction in Own Shares
Globenewswire· 2025-06-30 14:00
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS St Peter Port, Guernsey 30 June 2025 NB Private Equity Partners (“NBPE” or the “Company”) today announces details of Class A Shares bought back pursuant to general authority granted by shareholders of the Company on 12 June 2025 and the share buy-back agreement with Jefferies International Limited. Transaction on Lo ...
Digital Asset Technologies Portfolio Company, LiquidLink Launches Bitcoin Lightning and XRP ILP Nodes
Globenewswire· 2025-06-30 14:00
文章核心观点 - 数字资产技术公司旗下全资子公司LiquidLink在比特币闪电网络和瑞波的跨账本协议上推出企业级基础设施 为新兴的价值互联网奠定基础 [1] 分组1:LiquidLink业务进展 - 已在比特币闪电网络和瑞波的跨账本协议上推出企业级基础设施 有望成为价值互联网的基础枢纽 [1] - 目标是构建连接性最强的枢纽之一 连接碎片化的流动性池 实现网络间可靠结算 [2] - 计划支持比特币和瑞波账本上稳定币兴起带来的商业浪潮 近期法案为稳定币发行提供法律框架 加速了这一趋势 [3] - 下一节点里程碑是创建首个跨链流动性桥梁 连接比特币原生资产与瑞波账本 促进资产在两者间无缝流动 [4] - 节点业务独立运营 与旗舰平台XRPFY互补 计划用XRPFY为节点寻找低成本支付路径和跨网络交换机会 [5] 分组2:公司相关信息 - 数字资产技术公司是公开交易的投资发行商 通过子公司LiquidLink进入区块链技术领域 专注现实世界资产代币化等 [6] - LiquidLink是数字资产技术公司的投资组合公司 专注为代币化经济构建安全、可互操作的基础设施 旗舰产品XRPFY为瑞波账本生态系统提供工具 并将扩展支持多区块链 [7] 分组3:其他信息 - LiquidLink的闪电网络节点公共地址可在指定网站追踪 [6] - 提供数字资产技术公司的联系邮箱和官网链接 [6] - 提供LiquidLink的媒体联系人、官网和X(推特)账号信息 [7]
37/2025・Trifork Group: Weekly report on share buyback
Globenewswire· 2025-06-30 13:47
Company announcement no. 37 / 2025Schindellegi, Switzerland – 30 June 2025 Trifork Group: Weekly report on share buyback On 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 4 March 2025 up to and including no later than 30 June 2025. For details, please see company announcement no ...
Nextensa NV/SA : Nextensa launches the construction of Eosys at Cloche d'Or in collaboration with Promobe (joint venture Grossfeld)
Globenewswire· 2025-06-30 13:30
文章核心观点 Nextensa与Promobe通过合资企业Grossfeld合作,启动Eosys可持续办公楼建设并与普华永道卢森堡达成租赁协议,彰显了该地区发展潜力 [4] 项目情况 - Nextensa与Promobe通过合资企业Grossfeld启动Eosys办公楼建设 [4] - 普华永道卢森堡与项目方达成9488平方米办公空间15年租赁协议,将成主要租户 [4] - 项目面积12355平方米,预计2027年9月交付,普华永道约630名员工将入驻 [4][5] - 建筑由Andrew Philips设计,13层,金色阳极氧化铝立面,内部注重员工福祉和灵活性,目标获BREEAM“杰出”认证 [6] 地区情况 - Cloche d'Or由Nextensa和Promobe合资开发,集居住、工作、零售和休闲功能于一体 [7] - 2024年7月有轨电车线路开通,已建成超12万平方米办公空间,提供优质活力城市生态系统 [7] 公司情况 - Nextensa是综合房地产投资者和开发商,业务集中在卢森堡大公国、比利时和奥地利的办公、零售和住宅项目 [8] - Promobe是卢森堡大公国房地产开发主要参与者 [9]
Vallourec Secures a Significant OCTG Order with Abu Dhabi National Oil Company (ADNOC)
Globenewswire· 2025-06-30 13:30
文章核心观点 Vallourec获得阿布扎比国家石油公司(ADNOC)超30000吨碳钢管材及相关配件订单,此为双方石油专用管材(OCTG)长期协议一部分,订单生产将在巴西、中国和印尼的工厂进行,体现公司对ADNOC提供优质产品和服务的承诺 [1][3][4] 订单详情 - 公司获ADNOC超30000吨碳钢管材及带VAM特殊扣相关配件订单,属双方OCTG长期协议一部分 [1] - 协议含VAM现场服务和增值数字解决方案等综合服务,确保ADNOC油气田高效运营 [2] - 为满足供应和交付要求,生产将在巴西、中国和印尼的工业基地进行,订单契合ADNOC到2027年日产500万桶的目标 [3] 公司表态 - 公司高级副总裁称合同体现对ADNOC提供优质产品和服务的承诺,凭借中东运营经验和效率,持续为ADNOC等提供先进OCTG解决方案及服务 [4] 公司介绍 - 公司是能源市场和严苛工业应用领域优质无缝管解决方案全球领导者,有近13000名员工分布超20个国家,提供创新、安全、有竞争力和智能的管材解决方案 [4] - 公司在巴黎泛欧证券交易所上市,是CAC Mid 60、SBF 120和Next 150指数成分股,符合递延结算服务条件;在美国有一级美国存托凭证(ADR)计划,ADR与普通股比例为5:1 [5]
Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial
Globenewswire· 2025-06-30 13:30
文章核心观点 - 国际眼科公司Nicox宣布NCX 470 Denali 3期临床试验最后一名患者完成试验,预计2025年8月中旬至9月中旬公布 topline 结果,有望巩固NCX 470地位并确认其在青光眼市场潜力,公司还规划了后续多项里程碑 [1][2][3] 分组1:Denali 3期临床试验情况 - 试验评估NCX 470对开角型青光眼或高眼压患者的疗效和安全性,共696名患者入组,最后一名患者已完成治疗和随访 [1][2] - 试验对比每日一次剂量的0.1% NCX 470滴眼液与0.005%拉坦前列素滴眼液降低眼压的效果,由Nicox和其中国独家被许可方Ocumension共同资助 [3] - 该试验与已完成的Mont Blanc试验旨在满足NCX 470在美国和中国新药申请的临床监管要求,支持美国新药申请的药代动力学和非临床研究进展顺利 [3] 分组2:NCX 470产品情况 - NCX 470是新型一氧化氮供体比马前列素滴眼液,用于降低开角型青光眼或高眼压患者的眼压,已授权Ocumension用于中国、韩国和东南亚市场,授权Kowa用于日本市场 [3][7] 分组3:公司其他产品情况 - 公司首款产品VYZULTA®用于青光眼,已授权给博士伦在全球独家销售,在美国和其他15个地区商业上市 [7] - 公司从ZERVIATE®用于过敏性结膜炎的授权中获得收入,该产品已在多个地区授权,包括美国的Harrow公司以及中国和大多数东南亚市场的Ocumension Therapeutics [7] 分组4:未来关键里程碑 - Denali 3期临床试验 topline 结果预计2025年8月中旬至9月中旬公布 [2][6] - NCX 470在日本的3期临床疗效和长期安全性试验预计2025年下半年启动 [6] - NCX 470美国新药申请预计2026年上半年提交,前提是找到美国合作伙伴或获得必要资金 [3][6] 分组5:公司概况 - Nicox是一家国际眼科公司,致力于开发创新解决方案以维护视力和改善眼部健康,总部位于法国索菲亚安蒂波利斯,在泛欧证券交易所成长板上市,是CAC医疗保健指数成分股 [1][5][8]
Press release: Availability of the Q2 2025 Aide mémoire
Globenewswire· 2025-06-30 13:30
Availability of the Q2 2025 Aide mémoire Paris, France – June 30, 2025. Sanofi announced today that its Q2 2025 Aide mémoire is available on the "Investors" page of the company's website: Second quarter 2025 (sanofi.com) As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items, as well as the foreign currency impact and share count. Sanofi's second quarter 2025 results will be ...
Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
Globenewswire· 2025-06-30 13:00
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland – June 30, 2025 – Addex Therapeutics (SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced it has led a CHF 2 million investment in Stalicla, a clinical-stage company focused on precision medicine for neurodevelopmental and neuropsychiatric disorders. Stalicla will use the financing to advance its portfolio of autism focu ...